newsfilter
← Latest News
PR Newswire·

Medivir to present at the H.C. Wainwright 24th Annual Global Investment Conference

STOCKHOLM, Sept. 12, 2022 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that the company will present at the H.C